DE-089 Ophthalmic Solution

· Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DE-089 Ophthalmic Solution, covering 2012-11-14 to 2014-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye [Phase 3]